Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Stage 1 Pilot Test for Feasibility and Efficacy of a Multi-Level Intervention to Increase Physical Activity in Adults With Intellectual Disability: Physical Activity and Community EmPOWERment (PACE)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06740162
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:21.899025+00:00
Published At
2026-02-23T00:00:00+00:00
Record Updated At
2026-02-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Intellectual Disability", "Neurodevelopmental Disorders", "Autism Spectrum Disorder", "Down Syndrome", "Fragile X Syndrome", "Cri-du-Chat Syndrome", "De Lange Syndrome", "Mental Retardation, X-Linked", "Prader-Willi Syndrome", "Rubinstein-Taybi Syndrome", "Trisomy 13 Syndrome", "WAGR Syndrome", "Williams Syndrome"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-23"
protocolSection.identificationModule.nctId
"NCT06740162"
protocolSection.identificationModule.officialTitle
"A Stage 1 Pilot Test for Feasibility and Efficacy of a Multi-Level Intervention to Increase Physical Activity in Adults With Intellectual Disability: Physical Activity and Community EmPOWERment (PACE)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Intellectual Disability (protocolSection.conditionsModule.conditions)
  • Neurodevelopmental Disorders (protocolSection.conditionsModule.conditions)
  • Autism Spectrum Disorder (protocolSection.conditionsModule.conditions)
  • Down Syndrome (protocolSection.conditionsModule.conditions)
  • Fragile X Syndrome (protocolSection.conditionsModule.conditions)
  • Cri-du-Chat Syndrome (protocolSection.conditionsModule.conditions)
  • De Lange Syndrome (protocolSection.conditionsModule.conditions)
  • Mental Retardation, X-Linked (protocolSection.conditionsModule.conditions)
  • Prader-Willi Syndrome (protocolSection.conditionsModule.conditions)
  • Rubinstein-Taybi Syndrome (protocolSection.conditionsModule.conditions)
  • Trisomy 13 Syndrome (protocolSection.conditionsModule.conditions)
  • WAGR Syndrome (protocolSection.conditionsModule.conditions)
  • Williams Syndrome (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.